Podcasts about collaborations

In this episode of Reza Rifts, Veronica Cartwright shares her experiences in the entertainment industry, discussing her roles in various films and television shows, including 'Man on the Inside' and 'Alien.' She reflects on the evolution of humor in film, her memorable experiences with iconic actors, and the challenges of working in a changing industry. Cartwright also offers insights into directing styles, the impact of awards shows, and the importance of perseverance in pursuing one's passion for acting. Chapters 00:00 Introduction and Guest Introduction 02:52 Veronica Cartwright's Career Highlights 06:08 The Evolution of Humor in Film 08:45 Working on Spoofs and Comedic Roles 11:57 Insights from Iconic Films 14:47 Directing Styles and Collaborations 17:40 Challenges on Set and Behind the Scenes 20:32 Reflections on Wisdom and Early Career Experiences 24:04 Oscars and Award Shows: A Personal Perspective 26:48 Working with Jack Nicholson: Generosity and Influence 31:10 The Evolution of Film and Television: Breaking Stigmas 35:35 Memorable Roles and Experiences in Acting 38:38 Reflections on Career and Influences My IG and Facebook have not yet been reinstated!!

In this 50th edition of The World According to Irina Tsukerman, the bi-weekly geopolitical series on The KAJ Masterclass LIVE, we examine the SCO Summit, the China-Russia-North Korea axis, and rising tariff disputes with the US. Irina Tsukerman, a leading national security lawyer and geopolitical analyst, breaks down Nepal's political shifts, Europe's realignment over Russia, and the mounting crises in the Middle East. Gain sharp, authoritative insights into how these developments are reshaping global power dynamics and what they mean for the future of world politics.About the guestIrina Tsukerman is a human rights and national security lawyer, geopolitical analyst, editor of The Washington Outsider, and president of Scarab Rising, Inc., a media and security and strategic advisory. Her writings and commentary have appeared in diverse US and international media and have been translated into over a dozen languages.Connect with Irina here:https://www.thewashingtonoutsider.com/https://www.linkedin.com/in/irina-tsukerman-4b04595/In The World According to Irina Tsukerman, we embark on a fortnightly journey into the heart of global politics. Join us as we explore the complex geopolitical landscape, delve into pressing international issues, and gain invaluable insights from Irina's expert perspective. Together, we'll empower you with the knowledge needed to navigate the intricate world of global politics. Tune in, subscribe, and embark on this enlightening journey with us.Catch up on earlier episodes in the playlist here:https://www.youtube.com/playlist?list=PLt7IEKOM1t1tKItNEVaStzsqSChTCGmp6Watch all our global politics content here:https://khudaniaajay.substack.com/https://rumble.com/c/kajmasterclasshttps://www.youtube.com/@kajmasterclassPolitics

How do you build a tech company from scratch, scale it without venture capital, and sell it for $25 million? Sharon Gillenwater did exactly that—and today, she's sharing the secrets, lessons, and mindset that made it happen. If you're curious about entrepreneurship, bootstrapping, and making big impact, this is one conversation you can't miss!

In this episode, Amanda Rosevear speaks with Nick Adams, CEO of Sense, about the evolution of new business strategies in the experiential marketing sector. Nick shares insights from his extensive career, discussing the challenges agencies face in winning clients today, the importance of data in sales, and the shift towards more transactional relationships. Find out how Sense identifies their top prospects, the opportunities of collaborating with other agencies and the value of building genuine relationships in a fast-paced industry. 00:00 Introduction00:43 Meet Nick Adams, CEO of Sense01:09 Nick Adams' Career Journey03:22 Evolution of New Business Strategies06:08 Balancing Outbound and Inbound Marketing11:10 Challenges in Winning New Clients12:10 Specialising vs. Generalising in Brand Experience18:58 Importance of Data in New Business23:17 Impact of COVID on Client Relationships26:08 The Shift in Client Expectations27:14 The Importance of Chemistry in Client Relationships29:47 The Future of Relationship Building in Sales32:26 Adapting New Business Strategies34:00 Collaborations and Audience Segmentation38:30 Quickfire Questions with Nick43:30 Final Thoughts If you want to do business with the UK's leading brands, request an ALF Insight demo. Hosted on Acast. See acast.com/privacy for more information.

Pat Angeli revient sur l'histoire du tube mondial « World, Hold On » de Bob Sinclar. Il dévoile la collaboration avec Steve Edwards, les influences disco-funk du DJ français et les coulisses de ses autres succès comme « Love Generation » et « Rock This Party ».Notre équipe a utilisé un outil d'Intelligence artificielle via les technologies d'Audiomeans© pour accompagner la création de ce contenu écrit.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

On this episode of Gov Tech Today, we welcome Adam Silver, chair of the California Fair Political Practices Commission (FPPC). Adam explains the role of the FPPC as the state's political and ethics watchdog, overseeing campaign finance, lobbying rules, and conflicts of interest. We explore how the FPPC is pioneering the use of emerging technologies, from early adoption of Salesforce to current initiatives incorporating AI to promote transparency and efficiency. Adam also discusses the practicalities of filing requirements, the impact of making data public, and leveraging university partnerships and interstate collaborations for AI advancements. Plus, insights into ensuring human oversight in AI processes and maintaining meaningful transparency for the public.00:00 Introduction and Guest Welcome00:52 Understanding the FPPC01:47 FPPC's Technological Innovations02:18 Form 700 and Public Officials05:30 Data Transparency and AI Integration08:26 AI in Enforcement and Efficiency11:26 Human Resources and Change Management17:07 Collaborations and Future Plans23:12 Conclusion and Final Thoughts 

In this episode, host Sherry Bagley sits down with Jake Jacobs, executive director of Camp Henry, and Andrew Bobilya, professor and program director at Western Carolina University. The two reflect on their intertwined journeys in experiential education, sharing stories of influential mentors, professional reconnections, and the role of community in shaping their careers. They explore the power of relationship-building—both personal and professional—and highlight why communities of practice and care matter more than ever. Along the way, Jake and Andrew offer advice for emerging leaders on building lasting collaborations, grounded in vulnerability, commitment, and a relationship-first mindset. From PhD programs to outdoor adventures, their conversation shows how shared experiences can create lifelong partnerships and meaningful impact.   It's in the Experience is produced by Association Briefings.

Ever wondered how singers record vocals remotely and make them sound professional? In this episode of Inside The Mix, Marc Matthews is joined by New Zealand synthwave vocalist INDIGO to explore the art of remote vocal collaboration and the songwriting process behind her unique sound.From her unexpected start in the synthwave scene to collaborations with artists like Wolf Club and Turbo Knight, INDIGO shares how she records vocals from home while working with producers across the world. We dive into her vocal recording techniques—including why she double-tracks every vocal and prefers recording in the evenings for her best takes.You'll also learn how Indigo adapts her lyrics to fit electronic music, moving between dreamy love songs and darker themes, and how she overcomes songwriter's block with practical strategies like listening to instrumentals on long drives or stepping away from projects overnight.For the tech-minded, Indigo reveals her setup, using the Aston Origin microphone, basic vocal processing, and clear communication with producers to make remote collaborations successful. She also opens up about the challenges of online music partnerships and why trust and reliability matter as much as technical skill.Whether you're a producer looking to collaborate with vocalists or a singer wanting to deliver better takes from home, this episode is packed with actionable tips for remote recording, lyric writing, and collaboration in the digital age.Links mentioned in this episode:Follow INDIGOListen to Darklight (feat. INDIGO)Listen to Engraved DisillusionSend me a message Support the showWays to connect with Marc: Book your FREE Music Breakthrough Strategy Call Radio-ready mixes start here - get the FREE weekly tips Grab exclusive access to BONUS content on Patreon Try Riverside for FREE Follow Marc's Socials: Instagram | YouTube | Synth Music Mastering Thanks for listening!!

Nicole shares 5 proven ways women entrepreneurs can boost revenue and shift their money mindset before year end — with strategies on repurposing offers, getting visible, quick wins, collaborations, and stepping into your CEO identity.If you're ready to grow your business, shift your money mindset, and step into the identity of a confident CEO, this episode is packed with practical strategy and powerful mindset shifts.We cover: How to repurpose and resell offers you've already created Why visibility and asking for the sale is non-negotiable Creating quick win offers that generate fast cash flow The power of collaborations and community Shifting your identity to align with the revenue you wantThese strategies are designed for women in business who are ready to scale, embrace abundance, and finish the year strong.Timestamps + Key Takeaways00:00 – Welcome to TGIM & why Q4 matters for women in business02:15 – People are always buying: the myth about tighter purse strings05:40 – Strategy 1: Repurpose and resell past offers for fast cash flow15:55 – Strategy 2: Get visible and confidently make the ask24:10 – Strategy 3: Create a quick win offer that converts30:45 – Strategy 4: Collaborations and networking that expand your reach39:20 – Strategy 5: Shifting your identity to align with revenue goals49:05 – Invitation to join Align CEO Method + free challengehttps://www.myalignedpurpose.com/challenge

In the midst of the pandemic and a life-threatening car accident, Carolyn Skowron found the courage to share her powerful story of overcoming depression, anxiety, and a non-verbal learning disability. In this inspiring episode, the author and public speaker opens up about her struggles, her journey to self-acceptance, and her mission to end the stigma surrounding mental health. Through her book "Unbreakable," Carolyn aims to provide hope and create more vulnerable conversations, reminding us that our challenges can become our greatest strengths.

Unlock your inner creative genius with invaluable lessons from Alex Murdock, a poet, storyteller, and performing artist. Learn how to find authentic self-expression through writing, harness the power of storytelling to captivate audiences, and build platforms that amplify diverse voices. Whether you're an aspiring writer, performer, or simply seek to ignite your creativity, this episode offers transformative insights to help you embrace your artistic journey with confidence.

Ryan Bukstein has spent his career shaping people-driven brands, from his early work at Ace Hotel to leading marketing at Vacation, and now as a consultant. In this conversation, he shares how collaboration, contrarian thinking, and a love of Japan are coming together in his latest project: a curated travel experience with the founders of clean beauty brand Dam Dam.More episodes with Ryan:Ace Hotel's Early Days: Punk Spirit and Hospitality InnovationThe Art of Turning Curiosity into Brand Equity: Lessons from Ace Hotel to Vacation & BeyondWhy Mentorship Matters Now More Than EverLearn more about Ryan's firm, SMPL, here. A few more resources: If you're new to Hospitality Daily, start here. You can send me a message here with questions, comments, or guest suggestions If you want to get my summary and actionable insights from each episode delivered to your inbox each day, subscribe here for free. Follow Hospitality Daily and join the conversation on YouTube, LinkedIn, and Instagram. If you want to advertise on Hospitality Daily, here are the ways we can work together. If you found this episode interesting or helpful, send it to someone on your team so you can turn the ideas into action and benefit your business and the people you serve! Music for this show is produced by Clay Bassford of Bespoke Sound: Music Identity Design for Hospitality Brands

A Special Interview with Sonny Moyers, author of The Architecture of the Real Estate Practice

Today we are joined by Gorkem and Batuhan from Fal.ai, the fastest growing generative media inference provider. They recently raised a $125M Series C and crossed $100M ARR. We covered how they pivoted from dbt pipelines to diffusion models inference, what were the models that really changed the trajectory of image generation, and the future of AI videos. Enjoy! 00:00 - Introductions 04:58 - History of Major AI Models and Their Impact on Fal.ai 07:06 - Pivoting to Generative Media and Strategic Business Decisions 10:46 - Technical discussion on CUDA optimization and kernel development 12:42 - Inference Engine Architecture and Kernel Reusability 14:59 - Performance Gains and Latency Trade-offs 15:50 - Discussion of model latency importance and performance optimization 17:56 - Importance of Latency and User Engagement 18:46 - Impact of Open Source Model Releases and Competitive Advantage 19:00 - Partnerships with closed source model developers 20:06 - Collaborations with Closed-Source Model Providers 21:28 - Serving Audio Models and Infrastructure Scalability 22:29 - Serverless GPU infrastructure and technical stack 23:52 - GPU Prioritization: H100s and Blackwell Optimization 25:00 - Discussion on ASICs vs. General Purpose GPUs 26:10 - Architectural Trends: MMDiTs and Model Innovation 27:35 - Rise and Decline of Distillation and Consistency Models 28:15 - Draft Mode and Streaming in Image Generation Workflows 29:46 - Generative Video Models and the Role of Latency 30:14 - Auto-Regressive Image Models and Industry Reactions 31:35 - Discussion of OpenAI's Sora and competition in video generation 34:44 - World Models and Creative Applications in Games and Movies 35:27 - Video Models' Revenue Share and Open-Source Contributions 36:40 - Rise of Chinese Labs and Partnerships 38:03 - Top Trending Models on Hugging Face and ByteDance's Role 39:29 - Monetization Strategies for Open Models 40:48 - Usage Distribution and Model Turnover on FAL 42:11 - Revenue Share vs. Open Model Usage Optimization 42:47 - Moderation and NSFW Content on the Platform 44:03 - Advertising as a key use case for generative media 45:37 - Generative Video in Startup Marketing and Virality 46:56 - LoRA Usage and Fine-Tuning Popularity 47:17 - LoRA ecosystem and fine-tuning discussion 49:25 - Post-Training of Video Models and Future of Fine-Tuning 50:21 - ComfyUI Pipelines and Workflow Complexity 52:31 - Requests for startups and future opportunities in the space 53:33 - Data Collection and RedPajama-Style Initiatives for Media Models 53:46 - RL for Image and Video Models: Unknown Potential 55:11 - Requests for Models: Editing and Conversational Video Models 57:12 - VO3 Capabilities: Lip Sync, TTS, and Timing 58:23 - Bitter Lesson and the Future of Model Workflows 58:44 - FAL's hiring approach and team structure 59:29 - Team Structure and Scaling Applied ML and Performance Teams 1:01:41 - Developer Experience Tools and Low-Code/No-Code Integration 1:03:04 - Improving Hiring Process with Public Challenges and Benchmarks 1:04:02 - Closing Remarks and Culture at FAL

We're kicking off the B&H Creators Green Room with the very talented Shuang Hu. Shuang is a renowned actress, writer, director, producer, and viral content creator with over 12 million followers. Tune in to learn about her creative journey, inspiration, and what it takes to grow as a modern creator.   Guest Bio: Shuang Hu is a talented Chinese-Australian actress, writer, director, producer, and content creator who has gained over 12 million followers since starting her online content in March 2020. Her YouTube channel, THEONESHU, was listed as one of the top 50 most viewed US channels by Tubefilter.com, and her most viral short-form video has received over 298 million views. Shuang has appeared in various TV shows, films, and plays. She also co-wrote, co-created, produced, and starred in Amazon Prime's first original feature film, "Five Blind Dates," launched in February 2024, and she aims to continue sharing engaging stories across different platforms.   Stay Connected   TikTok  Instagram YouTube   Credits  Host & Creative Producer: Deanna Tesa  Creative Producer: Elena Maidebura Creative Editor: Larissa Mattei Technical Producer: Mike Weinstein Executive Producer: Richard Stevens   Click here to Subscribe

Episode 269 of The Business Development Podcast takes us into Part 9 of the Podcast Playbook, where Kelly Kennedy breaks down the truth about marketing and growing a podcast. Launching a show is only the beginning — real growth comes from leveraging guests, showing up consistently on social media, using audiograms and clips to spark curiosity, repurposing content, building community, collaborating with other creators, and when the time is right, investing carefully in advertising where people are already listening. Kelly shares lessons learned firsthand, from early group-sharing strategies on LinkedIn to the difference between social media followers and true podcast listeners, offering practical ways to turn effort into momentum.At the heart of this episode is the reminder that podcast growth is not linear. It ebbs and flows like the stock market, with highs and lows that only make sense when you zoom out and stay consistent over time. Kelly emphasizes that you have to give yourself the time and runway to win — growth is slow and steady, but it compounds if you don't quit. For anyone looking to move from launch day into long-term success, this episode provides the roadmap and the mindset needed to keep showing up until the audience finds you.Key Takeaways: 1. Podcast growth is slow and steady, not instant — most people quit before the compounding effect kicks in.2. Leverage your guests by giving them clips, graphics, and recognition so they share your show with their networks.3. Social media is great for brand awareness, but it rarely converts directly into listens or downloads.4. Audiograms and short clips are powerful tools for promotion, especially when you highlight guest moments.5. Every episode is a content engine — repurpose it into quotes, carousels, blog posts, and newsletters.6. Paid advertising only works when you place it where people are already listening, like Spotify Ads.7. Social ads may grow followers, but true podcast success comes from loyal listeners, not vanity metrics.8. Building an email list or community deepens connection with listeners and keeps them engaged long term.9. Collaborations and cross-promotions with other podcasters and brands can dramatically expand your reach.10. You have to give yourself the time to win — growth ebbs and flows, but consistency and patience build loyal fans.✨ Join The Catalyst ClubIf you're ready to take your growth further, you don't have to do it alone. Inside The Catalyst Club, you'll find a private community of entrepreneurs, thought leaders, and creators who are walking the same journey as you. It's a place to share wins, ask for support, and surround yourself with peers who truly get it.The Catalyst Club was built for leaders like you — because if you know, you're known.

From new techniques to evolving best practices–are you up to date with the latest developments in carotid artery stenting? In this episode, Dr. Wayne Olan, Interventional Neuroradiologist and the director of Minimally Invasive Neurosurgery at George Washington University joins Dr. Michael Barraza for a discussion on the latest innovations and evolving techniques in carotid artery stenting.---This podcast is supported by:RADPAD® Radiation Protectionhttps://www.radpad.com/---SYNPOSISDr. Olan opens the conversation with a historical perspective on the evolution of carotid stenting, tracing advancements from early techniques to modern devices. He then talks through referral patterns, noting that the majority originate from cardiologists. Dr. Olan emphasizes the importance of meticulous periprocedural planning and comprehensive post-procedural management. Central to this discussion is the critical role of antiplatelet therapy, including strategies for addressing Plavix non-responders, such as the use of Integrilin. The discussions also covers advanced techniques in carotid artery stenting, including the utilization of the Aptus sheath and the Contego stent system. He underscores the importance of mastering the available tools, understanding patient-specific factors, meticulous procedural planning, and always maintaining a contingency plan. He concludes the discussion by exploring emerging trends and the future potential of outpatient carotid stenting.---TIMESTAMPS00:00 - Introduction02:44 - The Importance of Stroke Intervention07:16 - Carotid Stenting: Evolution and Techniques13:29 - Challenges and Collaborations in Carotid Interventions16:17 - Technical Insights and Best Practices25:24 - Choosing the Right Wire for Carotid Procedures25:53 - Anticoagulation and Filter Wire Techniques28:30 - Managing Stent Placement and Distal Protection30:54 - Handling Carotid Bifurcation and Skull Base Lesions38:43 Dealing with Tandem Occlusions42:06 - Future Trends in Outpatient Procedures44:43 - Addressing Re-stenosis and Vertebral Lesions45:44 - Conclusion and Final Thoughts

This week on the Dirt and Vert Podcast, we're honored to sit down with a true legend in the ultra running community, Jason Green from the Yeti Trail Runners!Jason takes us on a deep dive into the heart of the sport, from his own personal journey into ultra running to the wild evolution of the Yeti 100 race. He gets real about the challenges of race directing and the immense joy of creating a welcoming and inclusive space where every runner, no matter their pace, feels like a champion.We're talking about the crucial role of mentorship in keeping new runners in the sport, the authenticity that builds trust on the trails, and the lessons learned from those tough races that make us stronger. Jason's story is a powerful reminder that our sport is about so much more than just miles; it's about the shared experiences, random acts of kindness, and the laughter that defines our incredible community.Get ready for an honest, insightful, and inspiring conversation that embodies the very best of ultra running.Chapters00:00 Introduction to Yeti Trail Runners and Jason Green01:26 Jason's Journey into Ultra Running06:11 The Importance of Mentorship in Ultra Running11:32 Creating a Unique Race Experience19:02 Building a Community in Ultra Running21:56 Embracing Failure and Learning in Ultra Running28:22 Supporting Ultra Runners Through Tough Times31:32 The Importance of Community in Ultra Running38:24 Mentorship and Kindness in the Running Community41:16 The Passion Behind Ultra Running48:36 The Evolution of Yeti Races and Community Engagement51:16 Mentorship and Community in Ultra Running53:41 The Spirit of Early Races56:16 Lessons from Failure and Growth59:08 The Hardest Races and Personal Growth01:02:48 Memorable Race Experiences and Humor01:12:05 Pride in Accomplishments and Longevity in Racing01:13:54 The Beauty of Repeated Races01:16:37 Community and Connection in Ultra Running01:20:09 The Soul of Running01:22:17 Favorite Trail Events and Race Directing01:23:55 The Challenge of the Yeti 10001:28:11 Excitement for Dark Anchor's Move01:31:05 Collaborations and Future Events

In this episode, I explore why audience growth is the lifeblood of scalable success. I illustrate this with the remarkable example of Alex Hormozi—whose “$100 M Money Models” launch drew over 1 million registrants and delivered tens of millions in revenue. From there, I introduce three powerful strategies—collaborations, summits, and bundles—and share actionable insights and real‑world examples to help you expand your impact quickly. Throughout the episode, my message is clear: you must be intentional and proactive in building your audience. By embracing strategic collaborations, leveraging the concentrated exposure of summits, and crafting high-value bundles, you'll put yourself in a strong position to grow purposefully and sustainably. Key Takeaways from the Episode Why Audience Growth Matters A substantial and engaged audience is the foundation for launching high-impact projects and scaling business revenue (e.g., Alex Hermozi's $100M launch). Strategy 1: Collaborations & Partnerships Join forces with complementary creators or businesses to tap into new audiences. Cross-promotion grows reach while lending authority. Partnering allows shared resources, content co-creation, and collaborative momentum. Strategy 2: Hosting & Joining Summits Summits provide concentrated exposure to highly engaged communities. Being a presenter or participant increases credibility and positions you as a thought leader. Offers opportunities for deeper engagement, follow-up funnels, and content repurposing. Strategy 3: Bundles Bundling courses, products, or services creates compelling offers that attract broader audiences. Strategic bundling enhances perceived value and promotes cross-selling. Bundles can also be promotional partnerships—pairing your offer with others for mutual growth. Overarching Principles Be strategic: Choose collaborations, summits, and bundles that align with your brand and audience. Be proactive: Don't wait for ideal partners—reach out, propose, and create opportunities. Be intentional: Plan each growth strategy with clear goals and execution pathways. If you enjoyed this episode then please feel free to go and share it on your social media or head over to Apple podcasts or Spotify and give me a review, I would be so very grateful. LINKS TO RESOURCES MENTIONED IN TODAY'S EPISODE How to run a successful online summit with Krista...

Discover an alternative path to mental healing that challenges traditional psychiatric approaches. Learn how Dianetics counseling offers a unique method for overcoming trauma, resolving mental health challenges, and achieving personal transformation without medication or long-term therapy.

From teen club memories in Atlanta to viral fame on TikTok, K Camp sits down with Cam for a deep dive into music, life, and everything in between. They break down the highs and lows of navigating the industry, reflect on personal losses, and drop gems on balancing business with creative passion. Plus, K Camp gets candid about relationships, celebrity crushes, and the evolution of his sound. This episode is full of real talk, laughs, and legacy-building vibes.00:00- Introduction and Legacy00:37- Meet the Guest: K Camp01:54- Nostalgia and Musical Journey04:30- Finding His Sound05:56- Balancing Criticism and Confidence07:01- Growing Up in Atlanta08:28- Teen Club Memories11:21- Pursuing Music Seriously15:19- Financial Realizations and Business Acumen24:02- Understanding the Music Business34:43- Early Musical Influences36:15- Navigating Industry Beef36:47- Private Life and Relationships43:46- Dealing with Past Relationships55:01- Preferences in Women01:00:08- Celebrity Crushes01:02:25- The Trend of Older Women Dating Younger Men01:02:43- Respect for Influential Women01:03:40- Navigating Motives in Relationships01:06:14- The Importance of Thoughtful Gifts01:09:04- The Evolution of Fun and Responsibility01:14:54- The Impact of Viral Moments01:20:10- The Evolution of Sound and Staying Relevant01:25:59- Dealing with Personal Loss01:33:51- Reflecting on Vocal Cord Surgery01:35:12- The Strain of Touring and Vocal Issues01:38:42- Impact of Losses in the Atlanta Rap Community01:43:27- Balancing Business and Music01:45:10- Navigating the Music Industry Independently01:47:51- The Evolution of Mixtapes to Streaming01:58:49- Collaborations and Creative Processes01:59:49- Question of the Day: Choosing an Artist to Work With02:01:25- Stories Behind the Songs02:07:45- One Finger, One Pinky, One Thumb = One Love

In this Episode 49 of The World According to Irina Tsukerman, the bi-weekly geopolitical series on The KAJ Masterclass LIVE, we analyze key takeaways from the Alaska Summit, India-Russia-US dynamics, and the uncertain path of Gaza ceasefire talks. Irina also examines Trump's national security shake-ups, the Saudi intelligence leaks, and Japan's expanding Africa strategy. Designed for leaders, entrepreneurs, and decision-makers, this edition reveals how global power shifts directly shape business, strategy, and the future of leadership.About the guestIrina Tsukerman is a human rights and national security lawyer, geopolitical analyst, editor of The Washington Outsider, and president of Scarab Rising, Inc., a media and security and strategic advisory. Her writings and commentary have appeared in diverse US and international media and have been translated into over a dozen languages.Connect with Irina here:https://www.thewashingtonoutsider.com/https://www.linkedin.com/in/irina-tsukerman-4b04595/In The World According to Irina Tsukerman, we embark on a fortnightly journey into the heart of global politics. Join us as we explore the complex geopolitical landscape, delve into pressing international issues, and gain invaluable insights from Irina's expert perspective. Together, we'll empower you with the knowledge needed to navigate the intricate world of global politics. Tune in, subscribe, and embark on this enlightening journey with us.Catch up on earlier episodes in the playlist here:https://www.youtube.com/playlist?list=PLt7IEKOM1t1tKItNEVaStzsqSChTCGmp6Watch all our global politics content here:https://khudaniaajay.substack.com/https://rumble.com/c/kajmasterclasshttps://www.youtube.com/@kajmasterclassPolitics==================================

In this episode of Behind the Genes, we explore how Artificial Intelligence (AI) is being applied in genomics through cross-sector collaborations. Genomics England and InstaDeep are working together on AI and machine learning-related projects to accelerate cancer research and drive more personalised healthcare. Alongside these scientific advances, our guests also discuss the ethical, societal and policy challenges associated with the use of AI in genomics, including data privacy and genomic discrimination. Our guests ask what responsible deployment of AI in healthcare should look like and how the UK can lead by example. Our host, Francisco Azuaje, Director of Bioinformatics Genomics England is joined by Dr Rich Scott, Chief Executive Officer at Genomics England Karim Beguir - Chief Executive Officer at InstaDeep Harry Farmer – Senior Researcher at Ada Lovelace Institute If you enjoyed today's conversation, please like and share wherever you listen to your podcasts. And for more on AI in genomics, tune in to our earlier episode: Can Artificial Intelligence Accelerate the Impact of Genomics? "In terms of what AI's actually doing and what it's bringing, it's really just making possible things that we've been trying to do in genomics for some time, making these things easier and cheaper and in some cases viable. So really it's best to see it as an accelerant for genomic science; it doesn't present any brand-new ethical problems, instead what it's doing is taking some fairly old ethical challenges and making these things far more urgent."   You can download the transcript, or read it below.   Francisco: Welcome to Behind the Genes. [Music plays] Rich: The key is to deliver what we see at the heart of our mission which is bringing the potential of genomic healthcare to everyone.  We can only do that by working in partnership.  We bring our expertise and those unique capabilities.  It's about finding it in different ways, in different collaborations, that multiplier effect, and it's really exciting.  And I think the phase we're in at the moment in terms of the use of AI in genomics is we're still really early in that learning curve. [Music plays] Francisco: My name is Francisco Azuaje, and I am Director of Bioinformatics at Genomics England.  On today's episode I am joined by Karim Beguir, CEO of InstaDeep, a pioneering AI company, Harry Farmer, Senior Researcher at the Ada Lovelace Institute, and Rich Scott, CEO of Genomics England.  Today we will explore how Genomics England is collaborating with InstaDeep to harness the power of AI in genomic research.  We will also dive into the critical role of ethical considerations in the development and application of AI technologies for healthcare.  If you've enjoyed today's episode, please like, share on wherever you listen to your podcasts. [Music plays] Let's meet our guests. Karim: Hi Francisco, it's a pleasure to be here.  I am the Co-Founder and CEO of InstaDeep and the AI arm of BioNTech Group, and I'm also an AI Researcher. Harry: I'm Harry Farmer, I'm a Senior Researcher at the Ada Lovelace Institute, which is a think-tank that works on the ethical and the societal implications of AI, data and other emerging digital technologies, and it's a pleasure to be here. Rich: Hi, it's great to be here with such a great panel.  I'm Rich Scott, I'm the CEO of Genomics England. Francisco: Thank you all for joining us.  I am excited to explore this intersection of AI and genomics with all of you.  To our listeners, if you wish to hear more about AI in genomics, listen to our previous podcast episode, ‘Can Artificial Intelligence Accelerate the Impact of Genomics', which is linked in this podcast description. Let's set the stage with what is happening right now, Rich, there have been lots of exciting advances in AI and biomedical research but in genomics it's far more than just hype, can you walk us through some examples of how AI is actually impacting genomic healthcare research? Rich: Yeah, so, as you say, Francisco, it is a lot more than hype and it's really exciting.  I'd also say that we're just at the beginning of a real wave of change that's coming.  So while AI is already happening today and driving our thinking, really we're at the beginning of a process.  So when you think about how genomics could impact healthcare and people's health in general, what we're thinking about is genomics potentially playing a routine part in up to half of all healthcare encounters, we think, based on the sorts of differences it could make in different parts of our lives and our health journey.  There are so many different areas where AI, we expect, will help us on that journey.  So thinking about, for example, how we speed up the interpretation of genetic information through to its use and the simple presentation of how to use that in life, in routine healthcare, through to discovery of new biomarkers or classification that might help us identify the best treatment for people.  Where it's making a difference already today is actually all of those different points.  So, for example, there's some really exciting work we're doing jointly with Karim and team looking at how we might use classification of the DNA sequence of tumours to help identify what type of tumour - a tumour that we don't know where it's come from, so what we call a ‘cancer of unknown primary' - to help in that classification process.  We're also working with various different people who are interested in classification for treatment and trials, but there's also lots in between recognising patterns of genomic data together with other complex data.  So we've been doing a lot of work bringing image data together with genomic data and other health data so that you can begin to recognise patterns that we couldn't even dream of.  Doing that hand in hand with thinking about what patients and participants want and expect, how their data is used and how their information is held, bringing it all together and understanding how this works, the evidence that we need before we can decide that a particular approach is one that policymakers, people in healthcare want to use, is all part of the conversation. Francisco: Thank you, Rich, for speaking of cutting-edge AI applications and InstaDeep.  Karim, could you give us a glimpse into your work and particularly how your technologies are tackling some of the biggest challenges in genomic research? Karim: Absolutely, and I think what's exciting is we've heard from Rich and, you know, this is like the genomics expertise angle of things and I come from the AI world and so do most of the InstaDeep team.  And really what's fascinating is this intersection that is being extremely productive at the moment where technologies that have been developed for like multiple AI applications turn out to be extremely useful in understanding genomic sequences.  This is a little bit, our journey, Francisco.  Back in 2021/2022 we started working on the very intriguing question at the time of could we actually understand better genomic sequences with the emerging technologies of NLP, natural language processing.  And you have to put this in context, this was before even the word ‘generative AI' was coined, this was before ChatGPT, but we had sort of like an intuition that there was a lot of value in deploying this technology.  And so my team, sort of like a team of passionate experts in research and engineering of AI, we tackled this problem and started working on it and the result of this work was our nucleotide transformer model which we have open sourced today; it's one of the most downloaded, most popular models in genomics.  And what's interesting is we observed that simply using the technologies of what we call ‘self-supervised learning' or ‘unsupervised learning' could actually help us unlock a lot of patterns. As we know, most of genomics information is poorly understood and this is a way actually, with using the AI tool, to get some sense of the structure that's there. So how do we do this?  We basically mask a few aspects of the sequence and we ask the system to figure them out.  And so this is exactly how you teach a system to learn English, you know, you are teaching it to understand the language of genomics, and, incredibly, this approach when done at scale - and we train a lot on the NVIDIA Cambridge-1 supercomputer – allows you to have results and performances that are matching multiple specialised models.  So until then genomics and use of machine learning for genomics was for a particular task, I would have developed a specific model using mostly supervised learning, which is, I am showing you a few examples, and then channelled these examples and tried to match that, and so essentially you had one model per task.  What's really revolutionary in this new paradigm of AI is that you have a single model trained at very largescale, the AI starts to understand the patterns, and this means that very concretely we can work with our partners to uncover fascinating relationships that were previously poorly understood.  And so there is a wealth of potential that we are exploring together and it's a very exciting time. Francisco: What you're describing really highlights both the potential and the opportunities but also the responsibility we have with these powerful tools, its power, and this brings up some important ethical considerations.  And we have Harry…  Harry, we have talked about ethics frameworks in research for decades but AI seems to be rewriting the rulebook.  For your work at the Ada Lovelace Institute what makes AI fundamentally different from previous technologies when it comes to ethical considerations and how does this reshape our approach to ensuring these powerful tools benefit society as a whole? Harry: So I think when you are considering these sorts of ethical questions and these sorts of ethical challenges posed by AI and genomics it really depends on the sort of deployment that you're looking at.  From the conversation we've had so far, I think what's been hinted at is some of the diversity of applications that you might be using AI for within the context of genomics and healthcare.  So I think there's obviously big advances that have been alluded to in things like drug discovery, in things like cancer and cancer diagnosis, also these advances around gene editing, all of which have been on steroids, by artificial intelligence and particularly machine learning and deep learning. The area that we have been looking at at the Ada Lovelace Institute, and this was a project that we were doing in collaboration with the NCOB, the Nuffield Council on Bioethics, was looking at what we were calling ‘AI-powered genomic health prediction', which is very related to a technique called ‘polygenic scoring', for those who might be interested.  And that's looking at the emerging ability to make predictions about people's future health on the basis of their DNA, and it was thinking about what that ability might mean for UK society and also for how we are thinking about and delivering healthcare in the UK. Now, thinking about what the ethical challenges might be for that, I think you need to think about what specifically AI is bringing to that technique, so what it's bringing to genomic health prediction.  I think with some of the other deployments, the list of things that AI is bringing is quite similar, so it's helping with data collection and processing, so speeding up and automating data collection and preparation processes that otherwise are quite slow and very labour-intensive.  AI's also helping with the analysis of genomic and phenotype data, so helping us to understand the associations between different genomic variations and between observable traits, and this is something which without AI can often be prohibitively complex to do, and it's also sometimes suggested that on the deployment end AI can be a tool that can help us use genomic insight in healthcare more widely.  So one example of this might be using an AI chat bot to explain to a patient the results of a genomic test.  That's something that's only been mooted and I don't think there are current examples of that at the moment but that's one of the downstream applications of AI in the context of genomics. So in terms of what AI's actually doing and what it's bringing, it's really just making possible things that we've been trying to do in genomics for some time, making these things easier and cheaper and in some cases viable.  So really it's best to see it as an accelerant for genomic science; it doesn't present any brand-new ethical problems, instead what it's doing is taking some fairly old ethical challenges and making these things far more urgent.  So in terms of what those problems actually are, some of the big ones will be around privacy and surveillance, genomic health predictions produce a lot of intimate sensitive data about people and generating those insights requires the collection and the storage and the processing of a lot of very sensitive data as well.  We also have issues related to privacy around genomic discrimination, so this is the worry that people will be treated differently and in some cases unfairly on the basis of health predictions made about them.  And one of the really typical examples here is the worry that people might face higher insurance costs if they're found through genomic testing to be more likely to develop particular diseases over their life course. And then you also have a bunch of issues and questions which are more structural, so these are questions about how the availability of this kind of insight into people's future health might change or put pressure on existing ways of thinking about health and thinking about healthcare and some extreme cases thinking about the social contract.  So these are questions like does the viability of genomic health prediction lead to a radically more preventative approach to healthcare and what might this mean for what the state demands of you as a user of healthcare and as a recipient of that.  And there are also some important questions about the practicalities of delivering genomic medicine in the NHS, so questions like how does the NHS retain control and sovereignty over genomic analysis and data capacities, how do we test their efficacy at a public health level, and also – and this is something that we might talk about a bit later – what's the best deployment model for these capacities.  So that's some of the ethical and I think policy challenges that we need to be dealing with in this space. Francisco: Thank you, Harry.  And those principles you have outlined provide a solid foundation for discussing different types of applications. [Music plays] Let's talk about the InstaDeep and Genomics England partnership that is investigating the application of InstaDeep's powerful foundation model, the nucleotide transformer, and other cutting edge techniques to address several challenges in cancer research.  I have the privilege of working closely with this partnership and the potential here is immense.  Karim, could you break down for our listeners what you are working on together and what innovations you are aiming for? Karim: Absolutely, Francisco.  Actually, we are very excited by the collaboration with Genomics England.  Genomics England not only has one of the best data assets in the world when it comes to genomics, like a very well curated dataset but also a wealth of expertise on these topics, and on my side the InstaDeep team brings fundamental knowhow of machine learning models but also, as you mentioned, like powerful developed models already, such as our nucleotide transformer and others.  The culture of InstaDeep has always been to build AI that benefits everyone – this is literally in our mission – and so in particular, specifically on like current topics, really like the goal is to try to identify partners between genomic sequences of patients and the particular phenotypes or approaches.  And one of the key projects, which I mentioned that, is the one of cancer of unknown primary origin.  So when you have situations where you are not sure where a particular cancer emerged from it is critical to be able to extract this information to have the best potential care, and this is actually something where understanding of genomic sequences can bring this capability.  And so we've been getting some successful results in the collaboration but in many ways this is just the beginning.  What we are seeing is a great wealth of possibilities linking genotypes, so the information which is on the sequences themselves, the genomic sequences, and phenotypes, like the particular state of the patient, and the fact that the Genomics England team has those joint datasets creates incredible opportunities.  So we are looking at this really like identifying together what are the most useful ‘low-hanging fruits', if you want, in terms of like potentially improving a patient's care and moving forward from that. Francisco: And this collaborative approach you are describing raises questions about accelerating innovation in general.  When two organisations like Genomics England and InstaDeep come together it's like a multiplier effect in terms of expertise, data, and other resources.  Could you both share how this partnership is accelerating discoveries that might have taken years? Rich: Yeah, I mean, I think this…  Francisco, you frame it really nicely because this is what makes it so exciting to be in our position at Genomics England because what we do is we bring the particular understanding and expertise, digital infrastructure and custodianship of the National Genomic Research Library together, but actually the key is bringing the potential of genomic healthcare to everyone.  We can only do that by working in partnership, we bring our expertise and those capabilities.  And, as you say, it's about finding it in different ways, in different collaborations, that multiplier effect, and it's really exciting.  And I think the phase we're in at the moment in terms of the use of AI in genomics is we're still really early in that learning curve.  And so, as you've heard already through what Karim and I have said and also what Harry has said, there are multiple different aspects that we need to look at together, bringing different angles and understandings, and we see ourselves…  We often describe ourselves as a ‘data and evidence engine', that final word ‘evidence' is really important and it comes in the round.  So Harry really eloquently talked about a number of different considerations from an ethical perspective that need to be there.  What we need if we're going to move genomics forwards in terms of its potential to make a difference for people's lives, we need evidence around clinical efficacy of different approaches, that's absolutely a given and everyone always jumps at…  so it's almost first in line.  We need understanding about the health economics, you know, how much difference does it make for a particular investment, is it worth that investment.  Critically, it also is founded on, you know, how you might use this technology in different ways, how you use it in clinical pathways, you know, is it something that actually is addressing the particular questions which really hold back the delivery of better care.  Also in that evidence piece is an understanding of patients' and participants' expectations on how their data might be used, their expectations on privacy, the expectations that we have on understanding how equitable the use of a particular approach might be, or at least our understanding of how confident we are about the equity of the impact, and it's bringing together those different perspectives.  And that's one of the things that helps us construct the team at Genomics England so we have the expertise to help others access the data in the National Genomic Research Library for purposes our participants support but also help generate that sort of rounded package of evidence that will end up moving the dial.  So that it's not just about proving a cool widget, because that's great on its own, what drives Karim and the team is to make a difference in terms of outcomes, and that's exactly what drives us and our participants too. Francisco: And this and other partnership approaches brings up important questions about responsible innovation, and this naturally leads us to the next question for Harry, how do we harness these powerful tools when protecting our communities? Harry: Yeah, so if we are thinking about over-surveillance and the ways that vulnerable groups might be affected by the use of genomics and healthcare, I think we're talking about at least two different things here.  So one problems around the representativeness of data is it does lead to issues which you could classify as issues of differential accuracy.  So in the context of genomic prediction what you have is genomic predictive tools being more accurate for white Europeans and those with white European ancestry compared to other population groups.  And this is a product of the fact that genomic datasets and genomic predictions, the terminologies don't port well between different populations, which means if you train a genomic predictive tool on a bunch of people with white European ancestry the predictions you might make using that tool for other groups won't be as accurate as for the white Europeans.  And this can be actively harmful and dangerous for those in underrepresented groups because you are making predictions about people which just won't have the accuracy that you would expect in the context that you were deploying it. And I already mentioned this a bit in my previous answer, you have worries about discrimination, and there are a few different things here.  So with some historically marginalised groups and marginalised groups now there are longstanding historical sensitivities about being experimented on, about particular fears about eugenics and about being categorised in particular ways.  And it's worth saying here that there is obviously a racial dimension to this worry but I think there's also a class dimension, by which I mean you're far more vulnerable to being categorised unfavourably if you're poor or if you don't have a particular kind of status within society.  There is also within discrimination the idea that genomics might be used to explain away differences between different groups which in fact have a political or an economic basis.  So one example of this was during the COVID-19 pandemic, there were attempts by some commentators to explain away the fact that non-white communities had worse rates of mortality from COVID to try and attribute a genetic or a genomic basis to those differences rather than looking at some of the socioeconomic factors behind that.  So those are some worries as well. Now, when it comes to protecting particular groups I think there are a few things that can be done fairly straightforwardly.  So, one is work to improve the diversity and the representativeness of datasets.  Obviously, that's easier said than done, though it's a very clear thing that we can aspire towards and there is good work, I'm aware, that is going on in this space, some of which is being spearheaded by Genomics England, amongst other groups.  Another is just being very careful about how the results of population level genomic studies are communicated to avoid giving that impression of explaining away differences between different groups simply as things determined by genomics about which we can do nothing rather than things which have historical or socioeconomic bases.  But I also think the broader lesson is that some of these harms and these forms of discrimination are things that could theoretically affect anyone; they're not just limited to affecting marginalised groups. Genomic health predicting can produce bases for all of us to be discriminated against, things that have nothing to do with our race, our class, our sex or any other protected characteristic.  So I think there has to be thinking about how we establish or sure up more universal protections against genomic discrimination.  One thing that we can do here is simply stronger data protection law, and one of the things that we talk about in some of our reports is that how data protection law as it stands could do with being less ambiguous when it comes to how it treats genomic data and phenotype data produced as a result of genomic analysis. [Music plays] Francisco: Harry, you are in a unique position at the Ada Lovelace Institute where you bridge this gap between AI developers, researchers, policymakers and the public.  Your recent report on AI in genomics with the Nuffield Council on Bioethics offers an important blueprint for responsible AI innovation in general, so based on this cross-sector perspective, what guiding principles do we need to embrace as we navigate this intersection of AI and genomics? Harry: So I think in addition to the specific recommendations we set out in the final report of that work - which is called ‘Predicting the Future of Health' and which you can find on our website and also on the NCOB website – I think one of the biggest messages was the importance of finding a deployment model for genomic health prediction that respects that technology's strengths, what it can actually do, because there are limitations to this technology, and also which avoids circumstances in which the associated risks are difficult to deal with.  So another way of putting this is that we need a deployment model that, as well as making sure that we're ready to cope with the risks of genomic health prediction, the things like law, regulation and governance also proactively tries to design out some of those risks and finds ways of deploying this technology such that those risks don't present themselves in either as extreme a manner or don't present themselves in ways which makes them difficult to deal with. So one question that we posed in our research was whether some ways of integrating genomic health prediction may present more challenges regarding privacy, discrimination and then these other challenges that we'd identified around dependency and fragility and others. And having looked at some of the different broad approaches to using genomic health prediction within the NHS and within the UK's health system, we found that one presented by far fewest of the risks identified above, while still presenting some of the most certain benefits of genomic health prediction.  And this was using it really primarily as a targeted diagnostic tool - and this is a vision in which the NHS uses genomic health prediction quite sparingly in the first instance - and in situations to improve treatment and outcomes for those who are seriously ill or who have been identified as needing to take particular precautions regarding their health.  We think the more situational vision has a few advantages.  So one, is it allows patient and people using the health service to retain greater control over data.  We think that can also have a positive knock-on effect for worries about discrimination.  And here what you have is the absence of those pressures to share your data.  It means that it's easier for you as the user of the healthcare system to resist genomic discrimination simply by keeping your data private.  And there are some cases where that option… it shouldn't be the only option but where that option is really important. And then also one of the features of this vision is that the smaller scale of the use of genomic health prediction, presumed, can make outsourcing to third parties, which the NHS is probably likely to need to do in some cases.  It's also a vision, I think, that overall allows you to capture some of the more certain benefits to genomic health prediction which are about improvements to accuracy in predictions about people's future health at the margin, and therefore this is a deployment of this technology which is deploying it principally to people who will benefit and we know will benefit from marginal improvements in accuracy to predictions made about their future health rather than wanting to deploy those marginal improvements to the vast majority of the population where the benefit is less certain.  So this is a vision we hope sets out a way of getting some of the more certain benefits of this technology while minimising some of those broader more systemic risks. Francisco: Thank you, Harry.  Karim? Karim: Totally agree with Harry about the need for smart regulation in the field so that we make sure we have good uses of the technology but avoid the potential pitfalls.  I wanted to emphasise two points which I believe are important.  First, we are really in a fast-moving situation when we look at like AI progress.  We have seen incredible improvements over the last ten years and in particular what we call ‘artificial general intelligence', which is essentially systems that are matching human cognitive abilities, are now around the corner.  This might sound surprising but literally the last obstacles to reach AGI are being solved right now, and this means that in the next 12-24 months you will have systems that are incredibly capable.  So this emphasises the need for the type of measures and type of smart approach that Harry has described.  And I would say when you look at the intersection of AI and genomics this is a particularly important one and why it's the case, because so far in genomics our obstacle has not been data, it has been interpretation of a flood of data.  The progress that AI is making, like I just described now, means that very soon extraordinary capabilities will be available to improve patients' outcomes.  I want to inject a sense of how important is our conversation today, given what is happening, an exponential progress in AI, exponentially growing data in genomics and relatively exponential potential to build the technology for good.  But, like in other fields, we see that AI is an extremely powerful technology and we need to make sure it is used for good in fact and this is why the conversation that we have today is so important. Harry: Obviously I agree with the conclusion to all of this, is that we need to think very hard about the way that artificial intelligence and its deployment in healthcare and also just in many different walks of life is going to be affecting the way we think about public service delivery, affecting the way that we think about scientific development.  It's worth noting, though, that I think one of the biggest challenges from a policy perspective on artificial intelligence is being able to distinguish the wheat from the chaff.  There are obviously areas where AI has made huge and incredibly impressive progress over the past few years and where we reasonably expect that to continue over the next few years, but there are also areas where some of the stories being told about the capabilities of future systems probably won't be matched by the reality, but there is I think a really big and very live debate about exactly what we can reasonably expect from these technologies and therefore what the deployments of them are. Francisco: Thank you.  We are approaching the end of the episode and I'd like to conclude with a couple of questions.  Genomics England has built quite an ecosystem of industry partnerships, how do collaborations like the one with InstaDeep fit into your broader mission for the company? Rich: So linking this to the conversation that we've just been having, which is AI is making a real difference in terms of technologies that we can test, we can develop evidence on, and that is rightly creating excitement, I think our approach…  The expectation of our participants is that our role is to sit there and help people develop evidence and you can make judgments on policy based on those and that is what will drive adoption.  I think the thing that really excites me for the UK, most particularly in genomics, is our ability to be the place in the world where you can come with a new technology, whether it's genomic sequencing technology, whether it's a genomic AI approach to train that to develop evidence on its efficacy, and, if it's proven to be effective to be worth the bang for the buck to perform to the expectations that patients, the public, would have of it in terms of equity and so forth also to deploy it.  I think there is a real reason for excitement around that and it's a real opportunity that the government has highlighted and that we absolutely buy into that the UK can be the best place to do that for academics and for industry.  And our participants see real opportunity and are eager for that work to be done so that we have the evidence on which to decide what should be deployed and where.  We see opportunities in all sorts of different areas, so certainly in terms of drug discovery and all the way through to simplifying tasks which at the moment just limit the rate at which the existing uses of genomics in healthcare can happen. So I think there's opportunities across the whole length, if you like, the sort of end to end, and the breadth of opportunity, and industry, companies like InstaDeep and others that we work with, are really crucial to that.  And what we do is think about the digital infrastructure we need to, you know, have those teams able to interact with within the National Genomic Research Library carrying out their approved research projects.  Also what support they need, and that comes in different shapes and sizes, depending on the ask and also the company.  So sometimes sort of leaning in more, particularly at the start of programmes, to help people shape the question, working with our participants, thinking about the wider evidence that you might need, for example, those sort of things that Harry's touched on, but also thinking about what hands-on support companies need, because not every company is anywhere close to Karim and InstaDeep's expertise.  Sometimes this is also about supporting people to have some of those tools that they don't have or some of the knowhow that's very specific to areas of genomics, so it's absolutely crucial to it.  And I think that point of the UK being the place to come and develop that evidence in its full breadth so that policy decisions can be made not based on hype but on evidence in the round, on what will make a difference. Francisco: And, Karim, looking ahead, also in retrospect, what have been your key learnings about making this cross-sector partnership work? Karim: We live in an extraordinary time and I want to emphasise the potential of scientific discovery in the next two or three years.  AI is going to move from, let's say, digital style, you know, technologies like coding and maths towards more like science and biology.  In particular, genomics is going to be a fascinating area in terms of potential, and I agree with Rich and Harry, it's all in the end about proving on the ground the potential of those capabilities.  And at InstaDeep we are passionate about the tech – I think you might have felt that – but we're also passionate about the applications.  The best results come when you bring expertise from multiple domains; machine learning and AI experts will require the expertise of genomic experts, biologists, healthcare practitioners, to be able to translate the potential of those technologies in concrete outcomes.  And we've seen this on multiple successful projects we've done with Genomics England but really this suggests that we are going to have in the next 3-5 years way more progress than we had in the last five and really my wish is that collectively we seize this opportunity and we do it in a responsible and thoughtful manner. [Music plays] Francisco: We'll wrap up there.  Thank you to our guests, Karim Beguir, Harry Farmer and Rich Scott, for joining me today as we discuss the role of AI in genomics research.  If you wish to hear more like this, please subscribe to Behind the Genes on your favourite podcast app.  Thank you for listening.  I have been your host, Francisco Azuaje.  This podcast was edited by Bill Griffin at Ventoux Digital and produced by Naimah Callachand. [Music plays]    

A special conversation with author Dr. Josh McConkey on their book “Be the Weight Behind the Spear.”

A special conversation with author Ryan T. Reichert on their book “God Only Knows When the Devil Comes for You: A Second Chance at Life.”

A special conversation with author Deborah Coviello on their book “The CEO's Compass: Your Guide to Get Back on Track.”

Forests thrive when people work together. In this episode, we talk with Kes Ebbs of The Nature Conservancy and Theresa Floberg of Dovetail Partners about partnering with the U.S. Forest Service to keep Northeastern Minnesota's woods healthy and resilient.Show Notes:Dovetail PartnersThe Nature Conservancy in MinnesotaSuperior National Forest

Why do genius hardware ideas fail while simple ones dominate the market? Capital equipment strategist Prachurya Bharadwaj reveals how to align deep technical R&D with ruthless business scalability across continents. Learn how global politics influence right down to your material choices and how to build a team that can execute from vision to manufacturing dominance

Cet épisode est présenté par Squarespace.Vous voulez lancer votre marque, votre projet ou votre portfolio ?Squarespace est l'outil que j'aurais rêvé d'avoir à mes débuts : templates élégants, boutique en ligne intégrée, paiement sécurisé, gestion des stocks, emailing, optimisation SEO… tout en un, sans développeur et sans prise de tête.Essayez 14 jours. -10 % avec le code BOLD → squarespace.com/BOLD

Highlights of Wharton Marketing Matters episodes featuring Connor Blakley, founder of Youth Logic, discussing the origins of his company, how to effectively reach Gen Z, and the missteps brands often make with this generation, and David Picioski, Head of Global Brand Partnerships and Collaborations at Wilson Sporting Goods Co., who shares insights on Wilson's partnership with the NBA, relationships with players, the brand's ambassadorship with Caitlin Clark, and the role of technology in product innovation. Hosted on Acast. See acast.com/privacy for more information.

Welcome back to another episode of the Break/Fix Podcast, where we connect the past, present, and future of automotive and motorsport culture. In this episode, we're reaching for the stars—literally—as we sit down with the Owner and Director of Operations at Luna Replicas, a brand that blends the spirit of adventure with the precision of history. Known for their meticulously recreated NASA-era flight jackets, watches, and accessories, Luna Replicas celebrates the heroes of the space age through authentic, wearable art. But this isn't just about fashion - it's about legacy. We're joined by Max Kaiserman to explore how his team channels their passion for aerospace (and Motorsports) history into every stitch, and how the automotive and motorsports communities have embraced these designs for their shared love of engineering excellence, exploration, and bold storytelling. So, buckle up for a conversation that's going to be out of this world! ===== (Oo---x---oO) ===== 00:00 Meet Max Kaiserman of Luna Replicas 01:58 Max's Early Passion for Space and Motorsports 03:33 The Origin Story of Luna Replicas 07:03 Involvement in the Ford vs. Ferrari Movie 12:30 The Shelby Cobra Van 18:54 Apollo 15 (Astrovette) Corvette Restoration 25:04 Connections Between Space Exploration and Motorsports 31:03 Customer Stories and Historical Connections 33:58 Challenges in Sourcing and Manufacturing 37:33 Innovative Projects and Future Plans 44:51 Collaborations and Community Engagement 46:48 Final Thoughts and Shoutouts ==================== The Motoring Podcast Network : Years of racing, wrenching and Motorsports experience brings together a top notch collection of knowledge, stories and information. #everyonehasastory #gtmbreakfix - motoringpodcast.net More Information: https://www.motoringpodcast.net/ Become a VIP at: https://www.patreon.com/gtmotorsports Online Magazine: https://www.gtmotorsports.org/

Highlights of Wharton Marketing Matters episodes featuring Connor Blakley, founder of Youth Logic, discussing the origins of his company, how to effectively reach Gen Z, and the missteps brands often make with this generation, and David Picioski, Head of Global Brand Partnerships and Collaborations at Wilson Sporting Goods Co., who shares insights on Wilson's partnership with the NBA, relationships with players, the brand's ambassadorship with Caitlin Clark, and the role of technology in product innovation. Hosted on Acast. See acast.com/privacy for more information.

Join us as we explore the evolving landscape of US education with Dr. George Maurer, veteran journalist and education researcher. Dive into current trends shaping curricula, including topics like Critical Race Theory, while examining broader challenges in the American education system. Gain valuable insights on parent involvement and understanding your child's education. Whether you're a parent, educator, or concerned citizen, this episode offers a comprehensive look at modern learning environments and how to navigate them effectively.

On today's podcast episode, we discuss how to best decide who to partner with, the right conditions for a successful store-in-a-store relationship, and how to approach long-term partnerships versus one-off collaborations. Join Senior Director of Podcasts and guest host, Marcus Johnson, Vice President of Content, Suzy Davidkhanian, and the Founder and CEO of Mack Weldon, Brian Berger. Listen everywhere and watch on YouTube and Spotify.   To learn more about our research and get access to PRO+ go to EMARKETER.com   Follow us on Instagram at: https://www.instagram.com/emarketer/ For sponsorship opportunities contact us: advertising@emarketer.com For more information visit: https://www.emarketer.com/advertise/ Have questions or just want to say hi? Drop us a line at podcast@emarketer.com    For a transcript of this episode click here: https://www.emarketer.com/content/podcast-reimaging-retail-partnership-playbook-how-choose-powerful-collaborations-mack-weldon   © 2025 EMARKETER   Got an ecommerce challenge? Awin has you covered. With Awin's affiliate platform, brands of all sizes can unlock endless marketing opportunities, reach consumers everywhere, and choose partners that fit their goals. Control costs, customize programs, and drive real results. Learn more at awin.com/emarketer.

With constant change in the world as the norm, we're all faced with needing to think even bigger. Not only do we need to adapt to lead in the now. At the same time, we need to reimagine what's possible and build what's next. One way to do this is by leading to create world-changingRead More The post Leading to Build World-Changing Business Collaborations appeared first on Business Advancement.

Have you hesitated to use Collaborations as your strategy for organic growth? If you haven't tried a few collaborations yet, what you learn in this episode will make you eager to get started. Here's the backstory: Tina Bar On is our Member Success Coach, AND she owns a small online shop that she runs on a very part-time basis. Early last year, Tina decided that she was going to focus on Collaborations as her growth strategy for 2021. She committed to doing a Collaboration every month and finished out the year with 10 Collabs under her belt. I've been talking about the value of Collaborations to anyone who will listen for ages. So when Tina decided to do a “Year of collaborations” I made her promise to share her results in a case study. Listen in and you'll learn: Details about the Collaboration Events Tina ran Her best strategy to find Collaboration Partners The results of her “year of collaboration” Tina's best tips on how to make Collaboration Events easy and repeatable! Ready to collaborate and fast track your organic growth? https://classroom.thesocialsalesgirls.com/brand-collab-bootcamp ______________________ Are you constantly asking yourself how to make your website better or questioning your prices? Do you wonder if you're missing something? If you have made sales in person or on a site like Etsy, I know you can sell more on your site. Get my FREE mini-course that will show you our step-by-step process to grow your sales without spending a fortune on risky ad strategies or discounting your products here: https://learn.thesocialsalesgirls.com/conversion-school/ “Insightful, actionable and engaging! I learn so much every single time I listen. I can't believe this information is free!" - If you feel like this too, I'd love it if you would leave us a review. Reviewing the show will help us reach even more store owners, so we can help them grow their sales. Click here, tap to rate with 5 stars and select “Write a review”. Let us know what you find most helpful about the podcast! Also, if you haven't already make sure to follow the podcast so you don't miss an episode! Follow here!    

A special interview with author Andy Dietrich on his book “Play Stupid Games Win Stupid Prizes: Short stories about friendship, growth, and social misdemeanors.”Get the Book Here: https://www.andysbook.com/=================================

Reeya Banerjee shares her journey of reinvention, songwriting, and resilience—lessons in music, creativity, and transformation you can apply today. Her story is messy, real, and deeply human—turning grief, change, and challenge into songs that heal and connect. In this episode of KAJ Masterclass LIVE, she opens up about leaving the corporate grind, creating her album This Place, and what it truly means to reinvent yourself as an independent artist. You'll leave with timeless takeaways on authenticity, resilience, and how to channel your own story into a powerful comeback..

Interview with Debra Cohen, author of Jewish Palestine/Arab Palestine: A History of Conflict

Nick Tershay aka Nicky Diamonds is the founder of Diamond Supply Co., one of the most recognized brands in streetwear and skateboarding. Growing up in San Francisco in different group homes, he found a family in the emerging skate scene at Embarcadero. After turning pro and skating for different brands, Nick decided to start his own brand after designing hardware for skateboards. Inspired by a Sade song, he created Diamond and started making shirts with his logo. The shirts became incredibly popular, leading Nick to Los Angeles where he has been at the forefront of streetwear, fashion, and skating ever since. For promo opportunities on the podcast, e-mail info@historyofthebay.com--History of the Bay Spotify Playlist: https://open.spotify.com/playlist/3ZUM4rCv6xfNbvB4r8TVWU?si=9218659b5f4b43aaOnline Store: https://dregsone.myshopify.com Follow Dregs One:Spotify: https://open.spotify.com/artist/1UNuCcJlRb8ImMc5haZHXF?si=poJT0BYUS-qCfpEzAX7mlAInstagram: https://instagram.com/dregs_oneTikTok: https://tiktok.com/@dregs_oneTwitter: https://twitter.com/dregs_oneFacebook: https://facebook.com/dregsone41500:00 Nick's roots in SF04:13 Growing up in the city08:28 Early skating12:39 Embarcadero 18:17 Starting Diamond Supply Co 30:04 Skate fashion42:48 Beginnings of streetwear47:50 Developing a brand56:49 Collaborations 1:03:41 Relaunching the brand

Official show beginning 8:45Part 2 of the ongoing series, "what are humans?" This talk we dive deeper into some of the subjects covered in part one and advance into more talks on the mediocre explanation of Darwin and even Creationism for our human origins. We talk about the fossils, skeletons, and the lack of any transitional fossils in the fossil record. We talk about the possibility of Sasquatch being the most highly evolved species of primate that was part of the natural evolution.We start our talks on the human makeup and that human beings just don't fit into any part of the natural world. Listen to Unlocking the code: https://unlockingthecode.podbean.comWatch a demo version of Sacred Sight: https://rumble.com/v6rap16-sacred-sight-theatrical-version.htmlShow website:⁠https://www.chantitdownradio.com/⁠Youtube: ⁠https://www.youtube.com/channel/UCmTlBzFViiv58N4_K9On0UQ⁠Instagram: ⁠https://www.instagram.com/chantitdown/⁠Telegram:⁠https://t.me/chantitdown⁠Odysee: ⁠https://odysee.com/@chantitdownradio:c⁠Rumble: ⁠https://rumble.com/user/Chantitdownradio⁠Please help support the show. Subscribe, leave reviews, help algorithms find the show. Support the show if possible.Support Luemas in his new documentary join Patreon and get the extra show: Afterthoughts : ⁠https://www.patreon.com/Luemas⁠⁠https://www.chantitdownradio.com/store.html⁠Chant it down t-shirts: https://chant-it-down-store.creator-spring.com/listing/chant-it-down-logo

Join host Keith Reza for an engaging conversation with actor Charlie Talbert, known for his iconic role in Angus and appearances in Lisa Frankenstein, Your Honor, and Van Wilder. Charlie shares behind-the-scenes stories, his acting journey, overcoming speech impediments, and his latest projects. From hilarious anecdotes to deep reflections, this episode is a must-listen for film and acting enthusiasts!     00:00 – Welcome and Introduction   00:44 – Interview with Charlie Talbert Begins   01:08 – Charlie's Recent Projects and Experiences   04:11 – Memorable Moments from Angus   06:08 – Acting Techniques and Challenges   15:36 – Stand-Up Comedy and Writing   19:22 – Manifesting Opportunities in Acting   24:29 – Impact of Acting on Personal Lives   25:47 – Navigating Different Roles in Acting   27:29 – Reflections on Career and Collaborations   31:56 – Influence of Iconic Comedians   42:44 – Challenges and Fears in the Acting Industry   47:16 – Advice to Younger Self and Future Plans   50:55 – Closing Remarks and Future Projects    

Giora Schmidt is a virtuoso American-Israeli violinist. He has appeared as a soloist with many prominent symphony orchestras around the globe including the Atlanta, Chicago, Cleveland and Philadelphia symphonies and the Toronto, Vancouver and Israel Philharmonics. He has performed at Carnegie Hall, The Kennedy Center and The Metropolitan Museum of Art in New York. He has collaborated with Itzhak Perlman and Pinchas Zukerman. And he even performed on an airplane!My featured song is “Fishin'” featuring Mindi Abair on saxophone, from the album The PGS Experience by my band Project Grand Slam. Spotify link.------------------------------------------The Follow Your Dream Podcast:Top 1% of all podcasts with Listeners in 200 countries!Click here for All Episodes Click here for Guest List Click here for Guest Groupings Click here for Guest TestimonialsClick here to Subscribe Click here to receive our Email UpdatesClick here to Rate and Review the podcast—----------------------------------------CONNECT WITH GIORA:www.gioraschmidt.com____________________ROBERT'S NEWEST ALBUM:“WHAT'S UP!” is Robert's new compilation album. Featuring 10 of his recent singles including all the ones listed below. Instrumentals and vocals. Jazz, Rock, Pop and Fusion. “My best work so far. (Robert)”CLICK HERE FOR THE OFFICIAL VIDEOCLICK HERE FOR ALL LINKS—----------------------------------------Audio production:Jimmy RavenscroftKymera Films Connect with the Follow Your Dream Podcast:Website - www.followyourdreampodcast.comEmail Robert - robert@followyourdreampodcast.com Follow Robert's band, Project Grand Slam, and his music:Website - www.projectgrandslam.comYouTubeSpotify MusicApple MusicEmail - pgs@projectgrandslam.com 

In this Quick Tip episode, we're talking about smarter ways to grow your audience and attract your dream clients without wasting money or burning yourself out. First up—skip the Facebook “Boost” button! Instead, run proper ads that target a niche audience and give you measurable results. Next, make the most of free resources you already have—like ebooks, webinars, or live workshops—to attract new leads and build your email list (because the money really is in the list). From there, consider collaborating with complementary coaches and business owners to expand your reach through joint ventures, guest lives, or podcasts. Finally, don't just post and pray—monitor your analytics, track what's working, and stay ahead of trends by following platform experts who do the heavy lifting on updates for you. This episode is all about working smarter, not harder, so you can grow your business with intention.  

A special conversation with author Neena Perez on their book “Hit Me with Your Best Shot!: How I Overcame A Hard-Hitting Life.”

On this episode of The Karen Kenney Show, I dive into the idea that all relationships - whether personal or professional - are really just collaborations at heart. Inspired by a chat with my friend Emiline (aka: Emily Aborn – Copywriter and host of the Content with Character Podcast) and a nugget of wisdom from actor Ethan Hawke, I explore who we choose to “collaborate” with in life truly matters. It's not just about what looks good on paper -or- who's fun to be around for a quick minute.It's more about finding people who share your values, can communicate well, and genuinely want to see you thrive and shine!I share some of my own stories, too - both the good and the not-so-soothing – experiences of working with others. From college projects and yoga retreats to creative partnerships, the best collaborations always had trust, mutual respect, and a sense of fun at their core!On the flip side, I've also experienced those energy-draining partnerships where someone just isn't open or willing to trust the process or the other people…And let me tell you, that shit is a total grind you don't want to be stuck in. A big takeaway from this episode is the importance of knowing yourself before you jump into any kind of relationship or collaboration. Be honest about what you bring to the table, what you need, and what you're willing to give. And don't forget - sometimes the best collaboration you can have is with yourself, your creativity, or even your pets!

In this 48th edition of The World According to Irina Tsukerman, the bi-weekly geopolitical series on The KAJ Masterclass LIVE, we unpack decisive shifts in global politics — from India's potential Russia pivot and Trump's planned Putin talks to the Gaza flashpoint and rising U.S. influence in the Caucasus. Irina, a U.S.-based national security lawyer and geopolitical analyst, delivers sharp, fact-driven insights you won't find in mainstream coverage. Stay ahead of unfolding power plays that could redefine the world order.About the guestIrina Tsukerman is a human rights and national security lawyer, geopolitical analyst, editor of The Washington Outsider, and president of Scarab Rising, Inc., a media and security and strategic advisory. Her writings and commentary have appeared in diverse US and international media and have been translated into over a dozen languages.Connect with Irina here:https://www.thewashingtonoutsider.com/https://www.linkedin.com/in/irina-tsukerman-4b04595/In The World According to Irina Tsukerman, we embark on a fortnightly journey into the heart of global politics. Join us as we explore the complex geopolitical landscape, delve into pressing international issues, and gain invaluable insights from Irina's expert perspective. Together, we'll empower you with the knowledge needed to navigate the intricate world of global politics. Tune in, subscribe, and embark on this enlightening journey with us.Catch up on earlier episodes in the playlist here:https://www.youtube.com/playlist?list=PLt7IEKOM1t1tKItNEVaStzsqSChTCGmp6Watch all our global politics content here:https://khudaniaajay.substack.com/https://rumble.com/c/kajmasterclasshttps://www.youtube.com/@kajmasterclassPolitics

Financial fraud is evolving fast — are you ready to spot it before it hits? In this power-packed session, fraud prevention expert Sunny Banerjee shares insider strategies to detect, stop, and stay ahead of threats like BEC scams, pig butchering, and real-time payment fraud. Walk away with enterprise-level controls and simple, actionable steps to safeguard your business and clients for years to come.

- Ron Paul 90th Birthday Celebration and Reflections (0:10) - Ron Paul's Principles and Critique of Current Leadership (7:50) - Tulsi Gabbard's Speech and Political Influence (11:36) - Don Huffines Interview and Texas Comptroller Campaign (35:08) - Challenges and Opportunities in Texas Politics (40:35) - Gold and Silver as Legal Tender in Texas (49:33) - Alien Interstellar Object and Psychological Preparation (1:02:36) - The Role of Myths and Stories in Human Psychology (1:09:44) - Aliens, AI, and the Simulation Theory (1:13:53) - Religious and Technological Conflicts (1:21:28) - Decentralized Health and Peptide Therapy (1:25:59) - Peptide Therapy and Its Benefits (1:46:23) - Challenges and Misconceptions About Peptides (1:59:02) - Decentralizing Medicine and Personal Health Goals (1:59:17) - Practical Applications and Peptide Protocols (2:16:11) - Challenges and Solutions in Peptide Therapy (2:23:55) - Peptide Therapy and Long-Term Health (2:24:11) - Conclusion and Final Thoughts (2:24:23) - Oxytocin and Its Benefits (2:28:33) - Concerns About Peptide Supply Chain (2:30:17) - Peptides and Their Applications (2:32:31) - Beauty and Anti-Aging Peptides (2:41:36) - Challenges and Risks in the Medical System (2:50:53) - Decentralization and Health Independence (3:04:23) - Introduction to Unas (3:04:44) - Practical Steps for Setting Up a Una (3:06:58) - Advantages of Unas (3:23:05) - Future Plans and Collaborations (3:24:22) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com